Condition: Sarcopenia · Sarcopenia in Elderly · Sponsor: Chang Gung Memorial Hospital
Population aging has become a significant global concern, and Taiwan is set to officially enter the "super-aged society" in 2025. As individuals age, various physiological functions gradually decline, including a reduction in muscle mass, which is a key aspect of the aging process. This interventional study aims to investigate the effects of leucine-rich protein combined with polyunsaturated fatty acid supplementation on middle-aged and elderly individuals (aged 50 and above) who are at high risk for sarcopenia.
This description comes directly from the study's public registry record.
Hsiang-Yu Tang, Ph.D. · +886-3-2118800 · tangshyu@cgu.edu.tw
Yi Tsang Chen, Master of Science · +886-2-2712-2211 · ytchen@fpg.com.tw
Always discuss trial participation with your own doctor first.
| Chang Gung Memorial Hospital | Linkou District, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06991855